Key facts
- It has raised $39.2M; the latest was Accelerator/Incubator in Sep 2024.
- Notable investors include EIT Food, Almi Invest, Sofinnova Partners, Industrifonden, Bunge Ventures — 10 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 10 names
- ·Watchlist + deal alerts for Enginzyme
- ·The full record, as it builds
Funding rounds
No funding rounds for Enginzyme are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Enginzyme
Developer of a cell-free synthetic technology designed to make the chemical industry sustainable and green by unlocking the potential of enzymes. The company's technology enables biology to be used in standard chemical processing equipment at a large industrial scale by replacing traditional fossil-based manufacturing with a cell-free technology, enabling clients to get low-cost alternatives for cheap biomanufacturing processes.
- Sector
- Materials and Resources
- HQ
- Solna, Sweden
- Founded
- 2014
- Employees
- 30
- Website
- enginzyme.com/
- Ownership
- Privately Held (backing)
Enginzyme doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Enginzyme shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Enginzyme in its N-PORT filings yet. We sweep new filings monthly.